Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors.

Mantas Dmukauskas, Gino Cioffi, Corey Neff, Mackenzie Price, Kristin A Waite, Carol Kruchko, Justin M Barnes, Quinn T Ostrom, Jill S Barnholtz-Sloan

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Letter to the editor: Ethnicity in neuro-oncology research: how are we doing and how can we do better?Journal of neuro-oncology · 2025
Article
Associations between central nervous system tumor diagnosis stage and survival and Medicaid enrollment among children, adolescents, and young adults.Neuro-oncology practice · 2025
Article
State Public Assistance Spending and Survival Among Adults With Cancer.JAMA network open · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mantas DmukauskasTrans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Gino CioffiTrans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0002-3296-8652

Corey NeffCentral Brain Tumor Registry of the United States, Hinsdale, Illinois, USA.

Mackenzie PriceCentral Brain Tumor Registry of the United States, Hinsdale, Illinois, USA.

Kristin A WaiteTrans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

Carol KruchkoCentral Brain Tumor Registry of the United States, Hinsdale, Illinois, USA.ORCID https://orcid.org/0000-0001-7212-035X

Justin M BarnesDepartment of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.

Quinn T OstromCentral Brain Tumor Registry of the United States, Hinsdale, Illinois, USA.ORCID https://orcid.org/0000-0003-3469-7558

Jill S Barnholtz-SloanTrans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.ORCID https://orcid.org/0000-0001-6190-9304

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37051332

DOI10.1093/noajnl/vdad022

PMCPMC10084498

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.